Exelixis, Inc. - Common Stock (NQ:EXEL)

58.84 +0.45 (+0.78%)

Delayed Quote Updated: 1:15 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exelixis, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

23 24 Next >

Exelixis to Webcast Fireside Chats as Part of Investor Conferences in June

May 30, 2023

From Exelixis, Inc.

Via Business Wire

The Smartest Stocks to Buy With $20 Right Now and Hold Forever ↗

May 29, 2023

These companies can take investors on a lucrative ride, and all for the price of a few lattes.

Via The Motley Fool

2 Under-the-Radar Biotech Stocks to Buy in 2023 ↗

May 24, 2023

Companies that don't make a lot of noise can still make you a lot of money.

Via The Motley Fool

2 Unstoppable Growth Stocks to Buy in 2023 and Beyond ↗

May 20, 2023

Both Axsome Therapeutics and Exelixis have potentially game-changing products in their pipelines.

Via The Motley Fool

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

May 18, 2023

These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.

Via MarketBeat

8 Analysts Have This to Say About Exelixis ↗

May 10, 2023

Via Benzinga

Exelixis (EXEL) Q1 2023 Earnings Call Transcript ↗

May 10, 2023

EXEL earnings call for the period ending March 31, 2023.

Via The Motley Fool

Exelixis: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Nasdaq Bear Market: 5 Exceptional Growth Stocks You'll Regret Not Buying on the Dip ↗

May 13, 2023

A sizable dip in the innovation-driven Nasdaq Composite is the perfect excuse for investors to pounce on some phenomenal deals.

Via The Motley Fool

Exelixis Announces First Quarter 2023 Financial Results and Provides Corporate Update

May 09, 2023

From Exelixis, Inc.

Via Business Wire

Amid Proxy Challenge From Farallon, Exelixis' Board Member Resigns ↗

May 08, 2023

Exelixis Inc's (NASDAQ: EXEL) board member Lance Willsey announced his resignation from the Board,

Via Benzinga

Farallon Capital Management Comments on Successful Campaign for Change at Exelixis

May 07, 2023

From Farallon Capital Management L.L.C.

Via Business Wire

What 9 Analyst Ratings Have To Say About Exelixis ↗

April 12, 2023

Via Benzinga

Why Exelixis Stock Leaped More Than 4% Higher Today ↗

March 20, 2023

Oh, how some investors love stock buyback programs.

Via The Motley Fool

Analyst Ratings for Exelixis ↗

March 20, 2023

Via Benzinga

Exelixis Announces Departure of Lance Willsey, M.D. From Board of Directors

May 07, 2023

From Exelixis, Inc.

Via Business Wire

Exelixis to Present at the BofA Securities 2023 Healthcare Conference on May 10, 2023

May 03, 2023

From Exelixis, Inc.

Via Business Wire

Farallon Capital Urges Exelixis Shareholders to Support Change by Electing Its Three Highly Qualified Director Candidates

May 03, 2023

From Farallon Capital Management L.L.C.

Via Business Wire

Exelixis Files Definitive Proxy Statement and Mails Letter to Shareholders

May 01, 2023

From Exelixis, Inc.

Via Business Wire

Exelixis to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023

April 25, 2023

From Exelixis, Inc.

Via Business Wire

The Smartest Stocks to Buy With $20 Right Now and Hold Forever ↗

April 22, 2023

These cheap stocks have the potential to skyrocket over the long haul.

Via The Motley Fool

Nasdaq Bear Market: 5 Sensational Growth Stocks You'll Regret Not Buying on the Dip ↗

April 22, 2023

Opportunistic investors would be wise to pounce on innovative growth stocks following a 33% decline in the Nasdaq Composite.

Via The Motley Fool

Exelixis Advances Board Refreshment Plan

April 13, 2023

From Exelixis, Inc.

Via Business Wire

Exelixis Reiterates Commitment to Shareholder Value Creation

April 05, 2023

From Exelixis, Inc.

Via Business Wire

2 Under-the-Radar Biotech Stocks to Buy in 2023 ↗

April 05, 2023

Both companies have game-changing product portfolios that should result in stock price growth.

Via The Motley Fool

Facebook Turns To Generative AI For Help, FedEx Consolidates, UBS Executives Say Surprise Credit Suisse Deal 'Major Challenge:' Today's Top Stories ↗

April 05, 2023

Benzinga

Via Benzinga

Farallon Capital Might Undertake Proxy Fight Against Exelixis, Nominates Three Directors ↗

April 05, 2023

Via Benzinga

Farallon Issues Letter to Exelixis Board of Directors Outlining Case for Change

April 05, 2023

From Farallon Capital Management L.L.C.

Via Business Wire

2 Incredible Stocks to Buy With Less Than $25 ↗

April 04, 2023

Nothing beats a great investment for the price of just a few cups of coffee.

Via The Motley Fool

Exelixis Stock Shows Rising Relative Price Performance; Still Shy Of Key Benchmark ↗

March 27, 2023

In a welcome move, Exelixis stock saw its Relative Strength Rating improve to 73 on Monday, up from 69 a day earlier.

Via Investor's Business Daily

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.